Venture
PharmaCann Inc.
Latest Form D 2024-04-09- CIK 1621435
- State IL
- Other
- 19 Form D offerings since 2014-10-03
- Total sold
- $508M
- across 19 offerings
- Rounds
- 19
- Form D offerings since 2014-10-03
- Latest round
- $5M
- 2024-04-09 · 021-510003
- Investors
- 3
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2024-04-09 · $5M
- 2014-10-03$20M021-225798
- 2015-12-28$25M021-253918
- 2017-01-23$23.8M021-278955
- 2017-03-07$0021-281940
- 2018-07-02$22M021-315860
- 2020-05-11$19.6M021-366645
- 2020-09-23$35.9M021-376145
- 2021-03-19$31.9M021-392801
- 2021-06-25$110M021-404320
- 2021-07-09$85M021-405680
- 2022-07-08$25M021-451571
- 2022-11-07$2.2M021-464083
- 2023-04-05$12.9M021-478012
- 2024-04-09$7M021-509998
- 2024-04-09$10M021-509999
- 2024-04-09$35M021-510000
- 2024-04-09$27.7M021-510001
- 2024-04-09$10M021-510002
- 2024-04-09$5M021-510003
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($110M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-510003 | First filed2024-04-09 | Latest2024-04-09 | Sought$5M | Sold$5M | Investors3 | Exemptions506(b) |
| 021-510002 | First filed2024-04-09 | Latest2024-04-09 | Sought$10M | Sold$10M | Investors1 | Exemptions506(b) |
| 021-510001 | First filed2024-04-09 | Latest2024-04-09 | Sought$27.7M | Sold$27.7M | Investors1 | Exemptions506(b) |
| 021-510000 | First filed2024-04-09 | Latest2024-04-09 | Sought$50M | Sold$35M | Investors7 | Exemptions506(b) |
| 021-509999 | First filed2024-04-09 | Latest2024-04-09 | Sought$10M | Sold$10M | Investors1 | Exemptions506(b) |
| 021-509998 | First filed2024-04-09 | Latest2024-04-09 | Sought$7M | Sold$7M | Investors1 | Exemptions506(b) |
| 021-478012 | First filed2023-04-05 | Latest2024-04-09 | Sought$18M | Sold$12.9M | Investors6 | Exemptions506(b) |
| 021-464083 | First filed2022-11-07 | Latest2022-11-07 | Sought$25M | Sold$2.2M | Investors11 | Exemptions506(b) |
| 021-451571 | First filed2022-07-08 | Latest2022-07-08 | Sought$25M | Sold$25M | Investors3 | Exemptions506(b) |
| 021-405680 | First filed2021-07-09 | Latest2021-07-09 | Sought$85M | Sold$85M | Investors9 | Exemptions506(b) |
| 021-404320 | First filed2021-06-25 | Latest2021-06-25 | Sought$110M | Sold$110M | Investors1 | Exemptions506(b) |
| 021-392801 | First filed2021-03-19 | Latest2021-03-19 | Sought$33M | Sold$31.9M | Investors2 | Exemptions506(b) |
| 021-376145 | First filed2020-09-23 | Latest2020-11-13 | Sought$35.9M | Sold$35.9M | Investors134 | Exemptions506(b) |
| 021-366645 | First filed2020-05-11 | Latest2020-05-11 | Sought$25M | Sold$19.6M | Investors75 | Exemptions506(b) |
| 021-315860 | First filed2018-07-02 | Latest2018-07-02 | Sought$31M | Sold$22M | Investors22 | Exemptions506(b) |
| 021-281940 | First filed2017-03-07 | Latest2017-03-07 | Sought$550K | Sold$0 | Investors0 | Exemptions504 |
| 021-278955 | First filed2017-01-23 | Latest2017-01-23 | Sought$23.8M | Sold$23.8M | Investors6 | Exemptions506(b) |
| 021-253918 | First filed2015-12-28 | Latest2015-12-28 | Sought$25M | Sold$25M | Investors6 | Exemptions506(b) |
| 021-225798 | First filed2014-10-03 | Latest2014-10-03 | Sought$20M | Sold$20M | Investors1 | Exemptions506(b) |
Who backs PharmaCann Inc., inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2024-04-09
| Name | Relationship |
|---|---|
| Brett Novey | RelationshipExecutive Officer, Director |
| James Patrick Barry | RelationshipDirector |
| Lori Richards | RelationshipDirector |
| Stephen Schuler | RelationshipDirector |
| John McCarthy | RelationshipDirector |
| Patrick Unzicker | RelationshipExecutive Officer |
| Robert McQueen | RelationshipExecutive Officer |
| John Lord | RelationshipDirector |
Sales compensation
Named in Item 12 of its Form D filings
| Recipient | CRD | Broker-dealer | Offerings |
|---|---|---|---|
| Netshares Financial Services LLC | CRD307532 | Broker-dealer— | Offerings3 |
| Canaccord Genuity LLC | CRD1020 | Broker-dealer— | Offerings1 |
| Canaccord Genuity, LLC | CRD1020 | Broker-dealer— | Offerings1 |
| ENTORO SECURITIES, LLC | CRD35192 | Broker-dealer— | Offerings1 |
| GT SECURITIES, INC. | CRD116012 | Broker-dealer— | Offerings1 |
Facts
As its latest Form D states them
- Industry
- Other
- State
- Illinois (IL)
- Exemptions
- Rule 506(b); Rule 504(b)(1) (not (i), (ii) or (iii))
- First filed
- 2014-10-03
- Latest filing
- 2024-04-09
Who backs PharmaCann Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗